Stay updated on Combination Immunotherapy in SCLC Clinical Trial
Sign up to get notified when there's something new on the Combination Immunotherapy in SCLC Clinical Trial page.

Latest updates to the Combination Immunotherapy in SCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has been updated to reflect a new version of the study protocol, with changes in the principal investigator's name and the addition of collaborators. The detailed description of the study phases and inclusion/exclusion criteria has been removed, which may impact the understanding of the study's methodology.SummaryDifference44%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check94 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to Combination Immunotherapy in SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combination Immunotherapy in SCLC Clinical Trial page.